Evidence is limited for pulmonary surveillance.

Contralateral prophylactic mastectomy (CPM) is not recommended for average-risk women with breast cancer due to lack of evidence for survival benefit, yet recent studies demonstrate increasing CPM rates.

We identified patients with breast cancer treated with unilateral mastectomy (UM)…[Read more]